Inventiva to Showcase MASH Therapy Progress at Jefferies Healthcare Conference
Inventiva's CEO will present at Jefferies Global Healthcare Conference on June 3, 2026, highlighting clinical-stage advances in MASH treatment with lanifibranor.
IVAPhase 3 clinical trialbiopharmaceutical